Meningitis

Mass Immunization Effective Among Teens and Young Adults, But Not Very Young Children

Published in Vaccine Weekly, January 24th, 2001

Mass immunization is effective for controlling outbreaks or epidemics of serogroup C meningococcal disease among teenagers and young adults, but there is no evidence of protection in young children, according to an article in the January 10, 2001, issue of the Journal of the American Medical Association.

Philippe De Wals, PhD, of Sherbrooke University Hospital Center, Sherbrooke, Quebec, and colleagues studied the impact of a mass immunization campaign and assessed the vaccine effectiveness (VE) of serogroup C polysaccharide vaccine in controlling outbreaks of meningococcal disease (MCD). The authors analyzed MCD cases reported in Quebec from 1990 to 1998,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2001-01-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry